|
Volumn 477, Issue , 2000, Pages 145-153
|
Dipeptidyl peptidase IV in inflammatory CNS disease
a b a a a a c c c a b a |
Author keywords
Autoimmune disease; Dipeptidyl peptidase IV (DP IV, CD26); Experimental autoimmune encephalomyelitis; Inhibitors; T cell
|
Indexed keywords
CYTOKINE;
DIPEPTIDYL PEPTIDASE IV;
DIPEPTIDYL PEPTIDASE IV INHIBITOR;
ENZYME INHIBITOR;
MYELIN;
UNCLASSIFIED DRUG;
ALLERGIC ENCEPHALOMYELITIS;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
CONFERENCE PAPER;
CONTROLLED STUDY;
ENZYME INHIBITION;
FEMALE;
IMMUNOPATHOGENESIS;
IMMUNOREGULATION;
LYMPHOCYTE PROLIFERATION;
MOUSE;
NONHUMAN;
PRIORITY JOURNAL;
T LYMPHOCYTE ACTIVATION;
ANIMALS;
ANIMALS, OUTBRED STRAINS;
ANTIGENS, CD26;
AUTOIMMUNE DISEASES;
ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL;
FEMALE;
HUMANS;
LYMPHOCYTE ACTIVATION;
LYSINE;
MICE;
MULTIPLE SCLEROSIS;
MYELIN BASIC PROTEINS;
PYRROLIDINES;
RATS;
SERINE PROTEINASE INHIBITORS;
T-LYMPHOCYTE SUBSETS;
T-LYMPHOCYTES, HELPER-INDUCER;
THIAZOLES;
ANIMALIA;
|
EID: 0034472913
PISSN: 00652598
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (17)
|